B.A. Schrock Wealth Management, Inc.’s Regeneron Pharmaceuticals REGN Stock Holding History

B.A. Schrock Wealth Management, Inc.’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.61M	Buy	+2,188	New	+$1.65M	0.59%	53

Other funds holding REGN

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

B.A. Schrock Wealth Management, Inc.'s REGN Position: Q3 2026 in Review

B.A. Schrock Wealth Management, Inc. opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 2,188 shares worth $1.61M. The stake represents 0.59% of the portfolio and ranks #53 among its holdings.

149 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

B.A. Schrock Wealth Management, Inc. held 2,188 shares of Regeneron Pharmaceuticals worth $1.61M as of Q3 2026.
Regeneron Pharmaceuticals was a new B.A. Schrock Wealth Management, Inc. position in Q3 2026.
Regeneron Pharmaceuticals made up 0.59% of B.A. Schrock Wealth Management, Inc.'s portfolio in Q3 2026, its #53 holding.
149 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on B.A. Schrock Wealth Management, Inc.'s 13F filing for Q3 2026, filed 15 Oct 2026.